These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21145274)

  • 1. Statin therapy and cataract in type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab; 2011 Apr; 37(2):139-43. PubMed ID: 21145274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
    Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.
    Morieri ML; Avogaro A; Fadini GP;
    Cardiovasc Diabetol; 2020 Nov; 19(1):190. PubMed ID: 33172454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
    Sattar NA; Ginsberg H; Ray K; Chapman MJ; Arca M; Averna M; Betteridge DJ; Bhatnagar D; Bilianou E; Carmena R; Ceška R; Corsini A; Erbel R; Flynn PD; Garcia-Moll X; Gumprecht J; Ishibashi S; Jambart S; Kastelein JJ; Maher V; da Silva PM; Masana L; Odawara M; Pedersen TR; Rotella CM; Salti I; Teramoto T; Tokgozoglu L; Toth PP; Valensi P; Vergès B
    Atheroscler Suppl; 2014 Jun; 15(1):1-15. PubMed ID: 24840509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit.
    Amor AJ; Ortega E; Giménez M; Cofán M; Blanco J; Pané A; Boswell L; Vinagre I; Esmatjes E; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):512-519. PubMed ID: 31000451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
    Blom DJ; Ranjith N; Joshi P; Naidoo P; van Tonder A; Musa MG; Joshi S; Leisegang R; Trokis JS; Makan H; Raal FJ
    Cardiovasc J Afr; 2020; 31(5):245-251. PubMed ID: 33151240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
    Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
    Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
    Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
    Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of statin use with cataracts: a propensity score-matched analysis.
    Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
    JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.
    Chung YR; Park SW; Choi SY; Kim SW; Moon KY; Kim JH; Lee K
    Cardiovasc Diabetol; 2017 Jan; 16(1):4. PubMed ID: 28061854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.